机译:抗IL IL -13和抗IL IL -17A的组合施用在单独的亚治疗剂量上限制了TH2 / TH17高哮喘的小鼠模型中的哮喘状症状
Division of ImmunobiologyCincinnati Children's Hospital Medical CenterCincinnati Ohio;
Division of ImmunobiologyCincinnati Children's Hospital Medical CenterCincinnati Ohio;
Division of ImmunobiologyCincinnati Children's Hospital Medical CenterCincinnati Ohio;
Division of ImmunobiologyCincinnati Children's Hospital Medical CenterCincinnati Ohio;
Division of ImmunobiologyCincinnati Children's Hospital Medical CenterCincinnati Ohio;
Division of Pulmonary BiologyCincinnati Children's Hospital Medical CenterCincinnati Ohio;
Division of ImmunobiologyCincinnati Children's Hospital Medical CenterCincinnati Ohio;
Division of ImmunobiologyCincinnati Children's Hospital Medical CenterCincinnati Ohio;
Janssen Research &
Development LLCSpring House Pennsylvania;
Division of Pulmonary BiologyCincinnati Children's Hospital Medical CenterCincinnati Ohio;
Division of ImmunobiologyCincinnati Children's Hospital Medical CenterCincinnati Ohio;
机译:抗IL IL -13和抗IL IL -17A的组合施用在单独的亚治疗剂量上限制了TH2 / TH17高哮喘的小鼠模型中的哮喘状症状
机译:抗IL-13单克隆抗体在健康受试者和轻度哮喘患者中的1期,随机,安慰剂对照,剂量递增研究
机译:抗IL-13单克隆抗体在健康受试者和轻度哮喘患者中的1期,随机,安慰剂对照剂量递增研究
机译:在IL-4和IL-13信号下游的支气管哮喘骨膜纤维化中的脑膜纤维化的参与
机译:经过工程改造以过度表达IL-2,IL-7,IL-15或IL-21的肿瘤特异性人类原代T细胞可在免疫缺陷小鼠模型中赋予不同程度的肿瘤排斥反应和异种移植物抗宿主病。
机译:卵清蛋白诱导哮喘小鼠模型中的自然杀伤细胞分泌Th2细胞因子IL-5和IL-13
机译:在单独的亚治疗剂量时,抗IL-13和抗IL-17a的组合施用限制了TH2 / TH17高哮喘的小鼠模型中的哮喘状症状